These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15167156)

  • 1. Statistical approaches to handling uncertainty in health economic evaluation.
    Briggs AH
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):551-61. PubMed ID: 15167156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis.
    Lord J; Asante MA
    Health Econ; 1999 Jun; 8(4):323-33. PubMed ID: 10398525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The handling of uncertainty in economic evaluations of health care strategies].
    Siani C; Moatti JP
    Rev Epidemiol Sante Publique; 2003 Apr; 51(2):255-76. PubMed ID: 12876511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who's better not best: appropriate probabilistic uncertainty analysis.
    Coyle D
    Int J Technol Assess Health Care; 2003; 19(3):540-5. PubMed ID: 12962341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.
    Briggs A; Sculpher M; Buxton M
    Health Econ; 1994; 3(2):95-104. PubMed ID: 8044216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran.
    Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
    Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care.
    O'Brien BJ; Drummond MF; Labelle RJ; Willan A
    Med Care; 1994 Feb; 32(2):150-63. PubMed ID: 8302107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials.
    Doshi JA; Glick HA; Polsky D
    Value Health; 2006; 9(5):334-40. PubMed ID: 16961551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane.
    Briggs A; Fenn P
    Health Econ; 1998 Dec; 7(8):723-40. PubMed ID: 9890333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data.
    Willan AR; O'Brien BJ
    Health Econ; 1999 May; 8(3):203-11. PubMed ID: 10348415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity analysis in economic evaluation: a review of published studies.
    Briggs A; Sculpher M
    Health Econ; 1995; 4(5):355-71. PubMed ID: 8563834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-centred endpoints in economic evaluations of gastro-oesophageal reflux disease.
    Vakil N; Rydén-Bergsten T; Bergenheim K
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1469-80. PubMed ID: 12182747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease.
    Briggs AH; Goeree R; Blackhouse G; O'Brien BJ
    Med Decis Making; 2002; 22(4):290-308. PubMed ID: 12150595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp trial.
    Willan AR
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):543-9. PubMed ID: 15167155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models.
    Degeling K; IJzerman MJ; Koopman M; Koffijberg H
    BMC Med Res Methodol; 2017 Dec; 17(1):170. PubMed ID: 29246192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. At what price significance? The effect of price estimates on statistical inference in economic evaluation.
    Rittenhouse BE; Dulisse B; Stinnett AA
    Health Econ; 1999 May; 8(3):213-9. PubMed ID: 10348416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confidence intervals for cost/effectiveness ratios.
    Wakker P; Klaassen MP
    Health Econ; 1995; 4(5):373-81. PubMed ID: 8563835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis.
    Walker D; Fox-Rushby J
    Health Policy Plan; 2001 Dec; 16(4):435-43. PubMed ID: 11739369
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.